These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 30134857

  • 1. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
    Kordestani F, Mazloomi S, Mortazavi Y, Mazloomzadeh S, Fathi M, Rahmanpour H, Nazarian A.
    BMC Med Genet; 2018 Aug 22; 19(1):149. PubMed ID: 30134857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Missense Variant rs4645843 in TNF-α Gene Is a Risk Factor of Polycystic Ovary Syndrome in the Uygur Population.
    Li S, Zhao L, Wan XH.
    Tohoku J Exp Med; 2017 Oct 22; 243(2):95-100. PubMed ID: 28993561
    [Abstract] [Full Text] [Related]

  • 4. Relationship between leptin receptor and polycystic ovary syndrome.
    Li L, Lee KJ, Choi BC, Baek KH.
    Gene; 2013 Sep 15; 527(1):71-4. PubMed ID: 23769971
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
    Nsrallah AA, Abd-El Fatah AH, Ahmed HS.
    J Gene Med; 2019 Apr 15; 21(4):e3076. PubMed ID: 30743312
    [Abstract] [Full Text] [Related]

  • 6. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S, Huiya Z, Bo L, Wei W, Yongmei G.
    Endocrine; 2009 Dec 15; 36(3):503-9. PubMed ID: 19856137
    [Abstract] [Full Text] [Related]

  • 7. The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome.
    Yun JH, Choi JW, Lee KJ, Shin JS, Baek KH.
    Reprod Biol Endocrinol; 2011 Oct 04; 9():131. PubMed ID: 21970639
    [Abstract] [Full Text] [Related]

  • 8. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ, Shi YH, Zhao YR, Li Y, Tang R, Zhao LX, Chang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep 04; 39(9):582-5. PubMed ID: 15498182
    [Abstract] [Full Text] [Related]

  • 9. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.
    Gene; 2014 Mar 10; 537(2):245-52. PubMed ID: 24388959
    [Abstract] [Full Text] [Related]

  • 10. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
    Nambiar V, Vijesh VV, Lakshmanan P, Sukumaran S, Suganthi R.
    Eur J Obstet Gynecol Reprod Biol; 2016 May 10; 200():82-8. PubMed ID: 26995146
    [Abstract] [Full Text] [Related]

  • 11. A cross-sectional study to assess any possible linkage of C/T polymorphism in CYP17A1 gene with insulin resistance in non-obese women with polycystic ovarian syndrome.
    Banerjee U, Dasgupta A, Khan A, Ghosh MK, Roy P, Rout JK, Roy P, Dhara S.
    Indian J Med Res; 2016 Jun 10; 143(6):739-747. PubMed ID: 27748298
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.
    Makhdoomi MJ, Shah IA, Rashid R, Rashid A, Singh S, Shah ZA, Ganie MA.
    Biochem Genet; 2023 Aug 10; 61(4):1418-1432. PubMed ID: 36633772
    [Abstract] [Full Text] [Related]

  • 14. Evaluating the association of TNF α promoter haplotype with its serum levels and the risk of PCOS: A case control study.
    Bhatnager R, Jalthuria J, Sehrawat R, Nanda S, Dang AS.
    Cytokine; 2019 Feb 10; 114():86-91. PubMed ID: 30442458
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N, Hashim M, Sayed M, Said M.
    Dis Markers; 2009 Feb 10; 26(4):163-70. PubMed ID: 19729797
    [Abstract] [Full Text] [Related]

  • 16. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]

  • 17. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome.
    Thathapudi S, Kodati V, Erukkambattu J, Addepally U, Qurratulain H.
    Genet Test Mol Biomarkers; 2015 Mar 07; 19(3):128-32. PubMed ID: 25565299
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients].
    Diao XH, Shi YH, Gao Q, Wang LC, Tang R, Chen ZJ.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb 07; 43(2):106-9. PubMed ID: 18683748
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.